Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) announced that it had signed a contract to acquire medical diagnostic test manufacturer IQuum for a price of up to $450 million. The terms of the deal call for Massachusetts-based IQuum to receive $275 million up front from pharm industry titan Roche, and also receive up to another $175 million at a later date based on product milestones related to the success of IQuum products. Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), shares after opening at $36.60 moved to $36.64 on last trade day and at the end of the day closed at $36.39.
Energen Corporation (NYSE:EGN) agrees to sell its natural gas utility business Alabama Gas to Laclede Group (LG) for $1.28B in cash to focus on exploration and production. Energen Corporation (NYSE:EGN), shares fell 1.414% in last trading session and ended the day on $80.37. Energen Corporation (NYSE:EGN), return on equity ratio is recorded as 9.40% and its return on assets is 4.00%. Energen Corporation (NYSE:EGN), yearly performance is 60.74%.
Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM), is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that it started a collaboration with IsoTherapeutics Group of Houston, TX to complete studies required for introduction of a new manufacturing process for Actimab-A. Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), shares moved down 2.93% in last trading session and was closed at $11.60, while trading in range of $ 10.77 – 12.00. Actinium Pharmaceuticals Inc (NYSEMKT:ATNM),year to date (YTD) performance is 96.94%.
Idenix Pharmaceuticals Inc (NASDAQ:IDIX), weekly performance is -3.65%. On last trading day company shares ended up $5.81. Idenix Pharmaceuticals Inc (NASDAQ:IDIX), distance from 50-day simple moving average (SMA50) is -15.44%. Analysts mean target Price for the company is $5.40.